SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-029925
Filing Date
2024-04-03
Accepted
2024-04-03 17:19:31
Documents
2
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4286
2 POWER OF ATTORNEY ea020327302ex-24_cadrenal.htm EX-24 7462
  Complete submission text file 0001213900-24-029925.txt   13165
Mailing Address 818 A1A NORTH, SUITE 100 PONTE VEDRA BEACH FL 32082
Business Address
Cole Jeffrey Scott (Reporting) CIK: 0001751100 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41596 | Film No.: 24820102

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)